HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered balance of epidermis-related chemokines in epidermolysis bullosa.

AbstractBACKGROUND:
Epidermolysis bullosa (EB) is a congenital, refractory skin disease and there are no fundamental treatments. Recently, allogenic cell therapies are beginning to be applied as potential treatments, that are based on the concept that the allogenic cells can migrate into the skin and reconstitute the skin components. Although the mechanisms of cell migration into skin are not fully understood, chemokines are regarded as key factors in recruiting bone marrow-derived cells.
OBJECTIVES:
Our study aims to elucidate the expression of chemokines in the EB patients.
METHODS:
We determined the expression of wound-healing related chemokines in the sera, keratinocytes, and skin tissues of EB patients and compared them to those of healthy volunteers by enzyme-linked immunosorbent assays, quantitative reverse transcription PCR, and immunofluorescence staining.
RESULTS:
The serum levels of CXCL12 and HMGB1 were found to be significantly elevated in the EB patients. Conversely, the serum levels of CCL21 were found to be lower in the EB patients than in healthy controls. In addition, the serum levels of CXCL12 tended to increase and the serum levels of CCL27 tended to decrease with an increase in the affected body surface areas. To detect the origin of the circulating chemokines, we performed immunofluorescence staining. CCL21, CCL27, HMGB1 and CXCL12 were stained more broadly in the EB patient tissues than those in the control tissues.
CONCLUSIONS:
These results suggest that fluctuations in chemokine levels may contribute in a coordinated way to the wound-healing process and lend clues toward efficient cell therapies for EB.
AuthorsInkin Ujiie, Yasuyuki Fujita, Chihiro Nakayama, Wakana Matsumura, Shotaro Suzuki, Satoru Shinkuma, Toshifumi Nomura, Riichiro Abe, Hiroshi Shimizu
JournalJournal of dermatological science (J Dermatol Sci) Vol. 86 Issue 1 Pg. 37-45 (Apr 2017) ISSN: 1873-569X [Electronic] Netherlands
PMID28094098 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Chemokines, CC
  • HMGB1 Protein
  • HMGB1 protein, human
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cell Movement
  • Cell- and Tissue-Based Therapy (methods)
  • Chemokines, CC (blood, metabolism)
  • Child
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay
  • Epidermal Cells
  • Epidermis (metabolism)
  • Epidermolysis Bullosa (blood, metabolism, therapy)
  • Female
  • Fluorescent Antibody Technique
  • HMGB1 Protein (blood, metabolism)
  • Humans
  • Infant
  • Infant, Newborn
  • Keratinocytes (metabolism)
  • Male
  • Middle Aged
  • Wound Healing
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: